Open versus robotic-assisted kidney transplantation: A systematic review by the European Association of Urology (EAU) - Young Academic Urologists (YAU) Kidney Transplant Working Group.

Complicaciones postoperatorias Delayed graft function Open kidney transplantation Post-operative complications Retraso en la función del injerto Robotic-assisted kidney transplantation Trasplante renal abierto Trasplante renal asistido por robot

Journal

Actas urologicas espanolas
ISSN: 2173-5786
Titre abrégé: Actas Urol Esp (Engl Ed)
Pays: Spain
ID NLM: 101771154

Informations de publication

Date de publication:
10 2023
Historique:
received: 14 01 2023
revised: 24 01 2023
accepted: 25 01 2023
medline: 23 10 2023
pubmed: 26 3 2023
entrez: 25 3 2023
Statut: ppublish

Résumé

In the last 20 years, robotic assisted procedures were evaluated in the field of kidney transplantation to provide a mini-invasive approach for this particularly fragile population. As a relatively new issue, few studies compared open kidney transplantation (OKT) and robotic-assisted kidney transplantation (RAKT), mostly in small cohorts. To improve current knowledge, we wanted here to gather comparative data of OKT vs RAKT in a systematic review. A systematic review was performed according to preferred reporting items for systematic reviews and meta-analyses. Medline, Embase, and Cochrane databases were searched to identify all studies reporting post-operative outcomes of RAKT versus OKT. A total of 2136 patients in 13 studies were included. Median recipient age was 42.6 years (OKT: 43.5 years and RAKT: 40.3 years). Median preemptive kidney transplantation rate was 27.1 % (OKT: 23.3 % and RAKT: 33.2 %). Median total operative time and rewarming were respectively: 235 and 49 min in OKT population; 250 and 60 min in RAKT population. Post-operative complications rates were: 26.2 % in OKT population and 17.8 % in RAKT population. Delayed graft function rates were: 4.9 % in OKT population and 2.3 in RAKT population. Mid-term functional outcomes, patient and graft survival were similar in OKT and RAKT population. This systematic review showed that RAKT may be associated with a lower incidence of delayed graft function and post-operative surgical complications and similar mid-term functional outcomes, patient and graft survival, compared to OKT for end-stage renal disease patients.

Identifiants

pubmed: 36965855
pii: S2173-5786(23)00039-2
doi: 10.1016/j.acuroe.2023.03.003
pii:
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

474-487

Informations de copyright

Copyright © 2023 AEU. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

A Territo (A)

Uro-oncology and Kidney Transplant Unit, Department of Urology at "Fundació Puigvert" Hospital, Autonoma University of Barcelona, Barcelona, Spain.

A S Bajeot (AS)

Department of Urology and Kidney Transplantation, Rangueil University Hospital, Toulouse, France.

B Mesnard (B)

Department of Urology and Kidney Transplantation, Nantes University Hospital, Nantes, France.

R Campi (R)

Department of Urology, Florence University Hospital, Florence, Italy.

A Pecoraro (A)

Department of Urology, Florence University Hospital, Florence, Italy.

V Hevia (V)

Department of Urology, University Hospital Ramón y Cajal, Madrid, Spain.

A Piana (A)

Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.

N Doumerc (N)

Department of Urology and Kidney Transplantation, Rangueil University Hospital, Toulouse, France.

A Breda (A)

Uro-oncology and Kidney Transplant Unit, Department of Urology at "Fundació Puigvert" Hospital, Autonoma University of Barcelona, Barcelona, Spain.

R Boissier (R)

Department of Urology, La Conception University Hospital, Marseille, France.

T Prudhomme (T)

Department of Urology and Kidney Transplantation, Rangueil University Hospital, Toulouse, France. Electronic address: prudhomme.t@chu-toulouse.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH